Rexahn Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch REXN and buy or sell other stocks, options, and ETFs commission-free!

About REXN

Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. 

CEO
George Magrath, III, MD
CEOGeorge Magrath, III, MD
Employees
14
Employees14
Headquarters
Farmington Hills, Michigan
HeadquartersFarmington Hills, Michigan
Founded
2018
Founded2018
Employees
14
Employees14

REXN Key Statistics

Market cap
61.86M
Market cap61.86M
Price-Earnings ratio
-4.24
Price-Earnings ratio-4.24
Dividend yield
Dividend yield
Average volume
180.21K
Average volume180.21K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$6.60
52 Week high$6.60
52 Week low
$1.85
52 Week low$1.85
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.